A UCLA study has identified a hidden Achilles' heel in aggressive small cell cancers that have resisted new treatments for ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Explore how space oncology could transform cancer treatment through microgravity research and innovative drug development ...
A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine ...
As radiopharmaceutical therapy (RPT) expands beyond neuroendocrine tumors and prostate cancer, it is important to understand ...
MedPage Today on MSN
Recent developments in prostate cancer
Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...
Proceeds will fund advancement of ARON degrader, FX-111, to proof of concept and preclinical development of ARON RIPTAC program ...
A professor of Gastrointestinal and Urogenital Malignancies at the University of Uyo (UNIUYO), Prof. Emmanuel Kunle Abudu, ...
Phase 3 data suggest PSMA-PET-CT could reduce unnecessary prostate biopsies in selected high-risk men, though longer ...
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized C ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
Prostate cancer affects 1 in 8 men, but experts say it’s highly treatable when caught early. A survivor shares how PSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results